| UniProt ID | INGR2_HUMAN | |
|---|---|---|
| UniProt AC | P38484 | |
| Protein Name | Interferon gamma receptor 2 {ECO:0000312|HGNC:HGNC:5440} | |
| Gene Name | IFNGR2 {ECO:0000312|HGNC:HGNC:5440} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 337 | |
| Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Cytoplasmic vesicle membrane Single-pass type I membrane protein . Golgi apparatus membrane Single-pass type I membrane protein . Endoplasmic reticulum membrane Single-pass type I membrane protei |
|
| Protein Description | Associates with IFNGR1 to form a receptor for the cytokine interferon gamma (IFNG). [PubMed: 8124716] | |
| Protein Sequence | MRPTLLWSLLLLLGVFAAAAAAPPDPLSQLPAPQHPKIRLYNAEQVLSWEPVALSNSTRPVVYQVQFKYTDSKWFTADIMSIGVNCTQITATECDFTAASPSAGFPMDFNVTLRLRAELGALHSAWVTMPWFQHYRNVTVGPPENIEVTPGEGSLIIRFSSPFDIADTSTAFFCYYVHYWEKGGIQQVKGPFRSNSISLDNLKPSRVYCLQVQAQLLWNKSNIFRVGHLSNISCYETMADASTELQQVILISVGTFSLLSVLAGACFFLVLKYRGLIKYWFHTPPSIPLQIEEYLKDPTQPILEALDKDSSPKDDVWDSVSIISFPEKEQEDVLQTL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 56 | N-linked_Glycosylation | WEPVALSNSTRPVVY EEEEEECCCCCCEEE | 48.53 | 27599734 | |
| 85 | N-linked_Glycosylation | DIMSIGVNCTQITAT EEEEECCCCEEEEEE | 20.22 | 27599734 | |
| 110 | N-linked_Glycosylation | AGFPMDFNVTLRLRA CCCCCCCEEEEHHHH | 22.92 | 27599734 | |
| 137 | N-linked_Glycosylation | PWFQHYRNVTVGPPE CHHHCCCCCCCCCCC | 27.01 | 27599734 | |
| 198 | Phosphorylation | PFRSNSISLDNLKPS CCCCCCCCCCCCCCC | 29.50 | 17924679 | |
| 219 | N-linked_Glycosylation | VQAQLLWNKSNIFRV HHHHHHCCCCCCEEE | 37.54 | 27599734 | |
| 231 | N-linked_Glycosylation | FRVGHLSNISCYETM EEEECHHCCCCHHCC | 36.23 | 27599734 | |
| 308 | Ubiquitination | PILEALDKDSSPKDD HHHHHHCCCCCCCCC | 61.43 | - | |
| 319 | Phosphorylation | PKDDVWDSVSIISFP CCCCCCCCEEEEECC | 11.31 | 29514088 | |
| 321 | Phosphorylation | DDVWDSVSIISFPEK CCCCCCEEEEECCHH | 20.39 | 29514088 | |
| 324 | Phosphorylation | WDSVSIISFPEKEQE CCCEEEEECCHHHHH | 32.83 | 29507054 | |
| 328 | Ubiquitination | SIISFPEKEQEDVLQ EEEECCHHHHHHHHH | 66.01 | - | |
| 336 | Phosphorylation | EQEDVLQTL------ HHHHHHHHC------ | 30.21 | 29514088 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of INGR2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of INGR2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| JAK2_HUMAN | JAK2 | physical | 7673114 | |
| RL37A_HUMAN | RPL37A | physical | 21988832 |
| Kegg Disease | |
|---|---|
| H00089 | IFN-gamma/IL-12 axis, including the following five diseases: IL-12 p40 subunit deficiency; IL-12 rec |
| H00342 | Tuberculosis |
| OMIM Disease | |
| 614889 | Immunodeficiency 28 (IMD28) |
| Kegg Drug | |
| D00747 | Interferon gamma-1b (USAN/INN); Actimmune (TN) |
| D03357 | Interferon gamma-1a (genetical recombination) (JAN); Interferon gamma-1a; Biogamma (TN) |
| D08805 | Interferon gamma-n1 (JAN); Ogamma (TN) |
| DrugBank | |
| DB00033 | Interferon gamma-1b |
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-198, AND MASSSPECTROMETRY. | |